Anxiety moderates amyloid-beta association with cognition

January 29, 2015
Anxiety moderates amyloid-β association with cognition

(HealthDay)—For older adults, elevated amyloid-β (Aβ) levels correlate with cognitive decline, and elevated anxiety moderates these associations, according to a study published online Jan. 28 in JAMA Psychiatry.

Robert H. Pietrzak, Ph.D., from the U.S. Department of Veterans Affairs in West Haven, Conn., and colleagues examined the correlation between Aβ status and cognitive changes in a multicenter, prospective study. Three hundred thirty-three healthy, underwent assessments at baseline and at 18, 36, and 54 months.

The researchers found that positive Aβ (Aβ+) status at baseline correlated with a significant reduction in global cognition, , language, and executive function; these correlations were moderated by elevated anxiety symptoms. Slopes of cognitive decline were significantly more pronounced in the Aβ+ high-anxiety group than in the Aβ+ low-anxiety group, with Cohen d values of 0.78, 0.54, 0.51, and 0.39 for global cognition, verbal memory, language, and , respectively. The effects were independent of confounding variables such as age, educational level, APOE genotype, subjective memory complaints, and depressive symptoms. The correlation between Aβ and was not moderated by or subjective memory complaints.

"Given that there is currently no standard antiamyloid therapy and that anxiety symptoms are amenable to treatment, these findings may help inform risk stratification and management of the preclinical phase of Alzheimer's disease," the authors write.

Two authors disclosed financial ties to Cogstate Ltd., which provided some of the cognitive tests used in this study and contributed funding to the study.

Explore further: Tracing the impact of amyloid beta in mild cognitive impairment

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Tracing the impact of amyloid beta in mild cognitive impairment

January 15, 2013
The amount of amyloid β (Aβ) in the brains of people with mild cognitive impairment (MCI) is contributing to early memory loss, and increases with severity of symptoms, finds a study in BioMed Central's open access journal ...

The benefits of a spotless mind

November 15, 2013
Alzheimer's disease is an age-related memory disorder characterized by the accumulation of clumps of the toxic amyloid-β (Aβ) protein fragment in the extracellular space around neurons in the brain. Drugs that help to 'clean ...

Understanding the molecular mechanisms underlying Alzheimer's disease

June 10, 2013
The accumulation of amyloid-β (Aβ) in the brains of Alzheimer's disease (AD) patients is known to be associated with memory loss and neuronal degeneration, but the mechanism of Aβ pathogenesis is not fully understood.

Rescuing the golgi puts brakes on Alzheimer's progression

December 5, 2014
Alzheimer's disease (AD) progresses inside the brain in a rising storm of cellular chaos as deposits of the toxic protein, amyloid-beta (Aβ), overwhelm neurons. An apparent side effect of accumulating Aβ in neurons is the ...

Persistent depression linked with cognitive decline in older patients with coronary artery disease

March 5, 2012
Persistent depression symptoms may be associated with significantly greater declines in cognitive performance in older patients with coronary artery disease who underwent cardiac catheterization, according to a study published ...

No evidence of Alzheimer's disease-associated changes in adolescents carrying genetic risk factors

April 7, 2014
Two studies published in the Journal of Alzheimer's Disease indicate that some of the pathologic changes associated with Alzheimer's disease in older individuals are not apparent in young people who carry the apolipoprotein ...

Recommended for you

A depressed spouse may increase one's own cognitive decline, study finds

August 21, 2018
Researchers at Yale School of Public Health and their scientific partners have found that having a depressed spouse can increase one's own depressive symptoms as well as cognitive decline over time in late life. 

Study identifies 'compulsivity circuit' in heavy alcohol drinkers

August 21, 2018
Heavy alcohol drinkers attempt to acquire alcohol despite the threat of a negative consequence more so than light drinkers, a study in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging has found, and this behavior ...

Beauty is simpler, and less special, than we realize

August 20, 2018
Beauty, long studied by philosophers, and more recently by scientists, is simpler than we might think, New York University psychology researchers have concluded in a new analysis. Their work, which appears in the journal ...

Bilingual children who speak native language at home have higher intelligence

August 20, 2018
Children who regularly use their native language at home while growing up in a different country have higher IQs, a new study has shown.

People are more honest when using a foreign tongue, research finds

August 17, 2018
New UChicago-led research suggests that someone who speaks in a foreign language is probably more credible than the average native speaker.

FDA approves brain stimulation device for OCD

August 17, 2018
(HealthDay)—A brain stimulation device to treat obsessive-compulsive disorder (OCD) has received approval for marketing Friday by the U.S. Food and Drug Administration.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.